Back to Search Start Over

Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia.

Authors :
Brothers, Thomas D.
Lewer, Dan
Jones, Nicola
Colledge-Frisby, Samantha
Bonn, Matthew
Wheeler, Alice
Grebely, Jason
Farrell, Michael
Hickman, Matthew
Hayward, Andrew
Degenhardt, Louisa
Source :
International Journal of Drug Policy. Dec2023, Vol. 122, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

Transitional times in opioid use, such as release from prison and discontinuation of opioid agonist treatment (OAT), are associated with health harms due to changing drug consumption practices and limited access to health and social supports. Using a self-controlled (within-person) study design, we aimed to understand if these transitions increase risks of injection drug use-associated bacterial infections. We performed a self-controlled case series among a cohort of people with opioid use disorder (who had all previously accessed OAT) in New South Wales, Australia, 2001-2018. The outcome was hospitalisation with injecting-related bacterial infections. We divided participants' observed days into time windows related to incarceration and OAT receipt. We compared hospitalization rates during focal (exposure) windows and referent (control) windows (i.e., 5-52 weeks continuously not incarcerated or continuously receiving OAT). We estimated adjusted incidence rate ratios (aIRR) using conditional logistic regression, adjusted for time-varying confounders. There were 7590 participants who experienced hospitalisation with injecting-related bacterial infections (35% female; median age 38 years; 78% hospitalised with skin and soft-tissue infections). Risk for injecting-related bacterial infections was elevated for two weeks following release from prison (aIRR 1.45; 95%CI 1.22–1.72). Risk was increased during two weeks before (aIRR 1.89; 95%CI 1.59–2.25) and after (aIRR 1.91; 95%CI 1.54–2.36) discontinuation of OAT, and during two weeks before (aIRR 3.63; 95%CI 3.13–4.22) and after (aIRR 2.52; 95%CI 2.09–3.04) OAT initiation. Risk of injecting-related bacterial infections varies greatly within-individuals over time. Risk is raised immediately after prison release, and around initiation and discontinuation of OAT. Social contextual factors likely contribute to excess risks at transitions in incarceration and OAT exposure. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09553959
Volume :
122
Database :
Academic Search Index
Journal :
International Journal of Drug Policy
Publication Type :
Academic Journal
Accession number :
174036953
Full Text :
https://doi.org/10.1016/j.drugpo.2023.104218